SIONNA THERAPEUTICS, INC. Increase (Decrease) in Accounts Payable
SIONNA THERAPEUTICS, INC. (SION) reported Increase (Decrease) in Accounts Payable of -$323.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-06
- SIONNA THERAPEUTICS, INC. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was -$1.53M.
- SIONNA THERAPEUTICS, INC. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $1.21M, a 65.98% decline year-over-year.
- SIONNA THERAPEUTICS, INC. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was -$712.00K, a 165.80% decline year-over-year.
- SIONNA THERAPEUTICS, INC. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $567.00K.
- SIONNA THERAPEUTICS, INC. increase (decrease) in accounts payable for fiscal 2025 was -$417.00K, a 189.29% decline from fiscal 2024.
- SIONNA THERAPEUTICS, INC. increase (decrease) in accounts payable for fiscal 2024 was $467.00K.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$323.00K 10-Q · filed 2026-08-06 | -$1.03M derived: sum of 3 quarters · filed 2026-08-06 | -$468.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $1.21M 10-Q · filed 2026-05-12 | $497.00K derived: sum of 2 quarters · filed 2026-05-12 | $1.06M derived: sum of 3 quarters · filed 2026-05-12 | -$2.76M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$712.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$145.00K derived: sum of 2 quarters · filed 2026-03-02 | -$3.97M derived: sum of 3 quarters · filed 2026-08-06 | -$417.00K 10-K · filed 2026-03-02 |
| 2025-09-30 | $567.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$3.26M derived: sum of 2 quarters · filed 2026-08-06 | $295.00K 10-Q · filed 2025-11-05 | $1.38M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$3.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$272.00K 10-Q · filed 2026-08-06 | $810.00K derived: sum of 3 quarters · filed 2026-08-06 | -$950.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $3.55M 10-Q · filed 2026-05-12 | $4.64M derived: sum of 2 quarters · filed 2026-05-12 | $2.88M derived: sum of 3 quarters · filed 2026-05-12 | $2.35M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$678.00K derived: sum of 2 quarters · filed 2026-03-02 | -$1.20M derived: sum of 3 quarters · filed 2026-03-02 | $467.00K 10-K · filed 2026-03-02 |
| 2024-09-30 | -$1.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$2.29M derived: sum of 2 quarters · filed 2025-11-05 | -$615.00K 10-Q · filed 2025-11-05 | |
| 2024-06-30 | -$525.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $1.15M 10-Q · filed 2025-08-11 | ||
| 2024-03-31 | $1.67M 10-Q · filed 2025-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |